Related Experiment Video
Updated: Jun 30, 2026
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Statins in endothelial signaling and activation
1Section of Pulmonary and Critical Care Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA. jjacobso@medicine.bsd.uchicago.edu
Antioxidants & Redox Signaling
|September 24, 2008
Summary
Statins offer significant vascular protection beyond lowering lipids. These widely used drugs demonstrate therapeutic potential for vascular dysfunction through multiple cellular mechanisms.
Area of Science:
- Pharmacology
- Cardiovascular Science
- Cell Biology
Background:
- Statins are globally prescribed for lipid-lowering.
- Emerging evidence suggests pleiotropic effects of statins beyond cholesterol reduction.
Purpose of the Study:
- To explore the multifaceted mechanisms by which statins protect the vasculature.
- To highlight the therapeutic potential of statins in vascular dysfunction.
Main Methods:
- In vitro studies on endothelial cell (EC) function.
- Analysis of Rho GTPase regulation, NADPH oxidase activity, and NO bioavailability.
- Examination of differential gene expression.
- Review of animal model data.
Main Results:
- Statins modulate EC Rho GTPase signaling.
- Statins impact NADPH oxidase activity and nitric oxide (NO) bioavailability.
- Statins influence gene expression patterns.
- In vitro and animal studies consistently demonstrate vascular protection.
Conclusions:
- Statins provide significant vascular protection through diverse cellular pathways.
- These pleiotropic effects position statins as potential therapeutic agents for vascular diseases.
- Further research supports statins for treating conditions involving vascular dysfunction.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...